🇺🇸 FDA
Patent

US 11648287

Composition for the treatment of intracellular bacterial infection

granted A61KA61K31/7036A61K38/14

Quick answer

US patent 11648287 (Composition for the treatment of intracellular bacterial infection) held by ACADEMISCH MEDISCH CENTRUM expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADEMISCH MEDISCH CENTRUM
Grant date
Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/7036, A61K38/14, A61K41/0071, A61K45/06